A
Aminah Jatoi
Researcher at Mayo Clinic
Publications - 440
Citations - 15796
Aminah Jatoi is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 46, co-authored 404 publications receiving 12708 citations. Previous affiliations of Aminah Jatoi include University of Texas Health Science Center at San Antonio & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Cancer-associated weight loss: releasing its firm grip on negative clinical outcomes.
Naima Yusuf,Aminah Jatoi +1 more
TL;DR: This issue of Current Opinions in Supportive and Palliative Care takes the novel approach of focusing on weight loss in cancer patients who are receiving radiation, and draws attention to patients who often receive aggressive multimodality therapy, suffer high rates of severe weight loss, and yet appear to be a captive audience for a therapeutic intervention to help manage weight loss.
Journal ArticleDOI
Wanted--and Needed--more studies in geriatric lung cancer patients.
TL;DR: This study suggests that select patients who are among the oldest of the old can tolerate chemotherapy, and reports similar clinical outcomes based on tumor response rate, tumor progression-free survival, and overall survival among older and younger patients with chemotherapy.
Journal ArticleDOI
Osseous metastases: drugs that enhance bone integrity and prevent adverse skeletal events
James M. Heun,Aminah Jatoi +1 more
TL;DR: The evolving role of bisphosphonates and their side effects is discussed, other pharmacological interventions aimed at enhancing bone integrity are highlighted, and other pragmatic approaches to prevent worsening pain and fractures are reviewed.
Journal ArticleDOI
Integrative nutritional approaches to loss of weight and appetite in patients with advanced cancer
Richa Sood,Aminah Jatoi +1 more
TL;DR: The integrative approaches that have proven most effective to date for this sign and symptom are reviewed and some of the challenges of proving efficacy of palliative therapy are discussed.